FDA retaliation would be investigated by outside group under FDA reform bill -- Rep. Barton.
This article was originally published in The Tan Sheet
Executive Summary
FDA RETALIATION INVESTIGATIONS UNDER "INDEPENDENT" OUTSIDE PROCESS will be included in House legislation aimed at reforming FDA, House Commerce/oversight subcommittee Chairman Joe Barton (R-Tex.) promised in his opening statement during a Nov. 15 subcommittee hearing. "As this Congress moves forward on FDA reform...I will insist on an independent review process outside of FDA to handle cases" of alleged retaliation by the agency against industry, Barton said.
You may also be interested in...
Investigation Of FDA Employee Misconduct Charges Returns to OIG
A "stronger appearance of impartiality, integrity" will result from returning investigative authority over allegations of FDA employee misconduct to the Department of Health and Human Services Office of Inspector General, a House Energy and Commerce Committee aide says
Investigation Of FDA Employee Misconduct Charges Returns to OIG
A "stronger appearance of impartiality, integrity" will result from returning investigative authority over allegations of FDA employee misconduct to the Department of Health and Human Services Office of Inspector General, a House Energy and Commerce Committee aide says
Investigation Of FDA Employee Misconduct Charges Returns to OIG
A "stronger appearance of impartiality, integrity" will result from returning investigative authority over allegations of FDA employee misconduct to the Department of Health and Human Services Office of Inspector General, a House Energy and Commerce Committee aide says